Clinical Trial Update: Study of LYC-55716 in Adult Subjects With Locally Advanced or Metastatic Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial update for LYC-55716 in adults with locally advanced or metastatic cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• LYC-55716

Snippet

Sponsor: Lycera Corp. | Conditions: Cancer | Phase 1, Phase 2 | Status: COMPLETED